Evidence map›Paper›PMID 36899106›Full record

ArticleCell death and differentiation2023

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells.

Sara S Oltra, Sara Colomo, Laura Sin, María Pérez-López, Sara Lázaro, Angela Molina-Crespo, Kyoung-Han Choi, David Ros-Pardo, Lidia Martínez, Saleta Morales and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Inflammatory bowel disease and breast cancer: epidemiological evidence, shared biology, and clinical management.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Pyroptosis: Turning Up the Heat on Cancer.Annual review of immunology · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Sara S OltraFundación MD Anderson Internacional, Madrid, Spain.
Sara ColomoDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Laura SinFundación MD Anderson Internacional, Madrid, Spain.
María Pérez-LópezDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Sara LázaroFundación MD Anderson Internacional, Madrid, Spain.
Angela Molina-CrespoDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Kyoung-Han ChoiDepartment of Surgery, The Ohio State University Wexner Medical Center Columbus, Columbus, OH, 43210, USA.
David Ros-PardoMolecular Modeling Group, Centro de Biología Molecular Severo Ochoa, CBMSO Conexión Cáncer, (CSIC-UAM), Madrid, Spain.
Lidia MartínezDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Saleta MoralesDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Cristina González-ParamosDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain.
Alba OrantesCentro Nacional de Biotecnología (CNB), UAM-CSIC, Madrid, Spain.
Mario SorianoServicio de Microscopía Electrónica, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Alberto HernándezServicio de Microscopía Óptica Avanzada, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Ana LluchGEICAM, Spanish Breast Cancer Group, Madrid, Spain.ORCID 0000-0003-2766-407X
Federico RojoCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Joan AlbanellCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Paulino Gómez-PuertasMolecular Modeling Group, Centro de Biología Molecular Severo Ochoa, CBMSO Conexión Cáncer, (CSIC-UAM), Madrid, Spain.
Jae-Kyun KoDepartment of Surgery, The Ohio State University Wexner Medical Center Columbus, Columbus, OH, 43210, USA.
David SarrióDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), IdiPAZ, Madrid, Spain. dsarrio@iib.uam.es.
Gema Moreno-BuenoFundación MD Anderson Internacional, Madrid, Spain. gmoreno@iib.uam.es.ORCID 0000-0002-5030-6687
Instituto de Salud Carlos III · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESCentro de Biología Molecular Severo Ochoa · ESCentro de Investigacion Principe Felipe · ESThe Ohio State University Wexner Medical Center · USCentro Nacional de Biotecnología · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms (GSDMB1-4, that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon (GSDMB1-2) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2, and not exon 6-containing variants (GSDMB3-4), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies.

Indexed as

Breast NeoplasmsPyroptosisCaspasesFemaleGasderminsGranzymesHumansLeukocyte ElastaseNeoplasm ProteinsPeptide HydrolasesPore Forming Cytotoxic ProteinsProtein IsoformsCaspasesGasderminsGranzymesGSDMB protein, humanLeukocyte ElastaseNeoplasm ProteinsPeptide HydrolasesPore Forming Cytotoxic ProteinsProtein Isoforms

Identifiers

PMID36899106
PMCPMC10154425
OpenAlexW4323921205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.